Table 1.
Characteristics of the 8087 CM cases (2008–2012), total and stratified by sex
| Characteristics | Total | Women | Men | P-value* |
|---|---|---|---|---|
| n (%) | 8087 (100) | 4052 (50.1) | 4035 (49.9) | |
| Age (years), median (range) | 64 (2–98) | 62 (2–98) | 65 (14–98) | <0.001 |
| Age group, n (%) | <0.001 | |||
| <50 years | 1813 (22.4) | 1093 (27.0) | 720 (17.8) | |
| 50–69 years | 3417 (42.2) | 1622 (40.0) | 1795 (44.4) | |
| ≥70 years | 2857 (35.4) | 1337 (33.0) | 1520 (37.6) | |
| Regional Health Authority, n (%) | 0.230 | |||
| South-Eastern | 4957 (61.2) | 2473 (61.0) | 2484 (61.6) | |
| Western | 1728 (21.4) | 872 (21.6) | 856 (21.2) | |
| Central | 981 (12.2) | 512 (12.6) | 469 (11.6) | |
| Northern | 421 (5.2) | 195 (4.8) | 226 (5.6) | |
| Urban–rural area, n (%) | 0.451 | |||
| Urban | 3846 (47.6) | 1944 (48.0) | 1902 (47.2) | |
| Rural | 4241 (52.4) | 2108 (52.0) | 2133 (52.8) | |
| Anatomic site, n (%) | <0.001 | |||
| Trunk | 3656 (48.0) | 1368 (35.8) | 2288 (60.4) | |
| Head/neck | 1072 (14.0) | 497 (13.0) | 575 (15.2) | |
| Arm | 1055 (13.8) | 640 (16.8) | 415 (11.0) | |
| Leg | 1791 (23.6) | 1303 (34.0) | 488 (13.0) | |
| Other | 36 (0.4) | 20 (0.6) | 16 (0.4) | |
| Unspecified | 477 | 224 | 253 | |
| Melanoma subtype, n (%) | <0.001 | |||
| Superficial spreading | 4067 (68.2) | 2129 (70.6) | 1938 (65.8) | |
| Nodular | 1527 (25.6) | 686 (22.8) | 841 (28.6) | |
| Lentigo maligna | 229 (3.8) | 137 (4.6) | 92 (3.2) | |
| Acral | 32 (0.6) | 20 (0.6) | 12 (0.4) | |
| Other | 106 (1.8) | 42 (1.4) | 64 (2.2) | |
| Unspecified | 2126 | 1038 | 1088 | |
| Breslow thickness (mm), median (range) | 1 (0.1–70.0) | 1 (0.1–65.0) | 1.1 (0.1–70.0) | <0.001 |
| T-stage, n (%) | <0.001 | |||
| T1 (≤1.0 mm) | 3745 (51.8) | 2038 (56.0) | 1707 (47.6) | |
| T2 (1.01–2.0 mm) | 1561 (21.6) | 786 (21.6) | 775 (21.6) | |
| T3 (2.01–4.0 mm) | 1112 (15.4) | 469 (12.8) | 643 (18.0) | |
| T4 (>4.0 mm) | 812 (11.2) | 352 (9.6) | 460 (12.8) | |
| Unspecified | 857 | 407 | 450 | |
| Clark level, n (%) | <0.001 | |||
| II | 1484 (28.6) | 825 (31.2) | 659 (25.8) | |
| III | 1885 (36.2) | 927 (35.2) | 958 (37.4) | |
| IV | 1553 (29.8) | 752 (28.4) | 801 (31.4) | |
| V | 273 (5.2) | 135 (5.2) | 138 (5.4) | |
| Unspecified | 2892 | 1413 | 1479 | |
| Ulceration, n (%) | <0.001 | |||
| Present | 1200 (27.0) | 508 (23.0) | 692 (30.8) | |
| Not present | 3249 (73.0) | 1693 (77.0) | 1556 (69.2) | |
| Unspecified | 3638 | 1851 | 1787 | |
| Clinical stage, n (%) | <0.001 | |||
| Local | 6400 (91.8) | 3280 (93.8) | 3120 (89.8) | |
| Regional metastasis | 352 (5.0) | 140 (4.0) | 212 (6.2) | |
| Distant metastasis | 219 (3.2) | 77 (2.2) | 142 (4.0) | |
| Unspecified | 1116 | 555 | 561 | |
| Second primary CM, n (%) | <0.001 | |||
| 0 | 7851 (97.0) | 3963 (97.8) | 3888 (96.4) | |
| 1 | 215 (2.6) | 83 (2.0) | 132 (3.2) | |
| >1 | 21 (0.2) | 6 (0.2) | 15 (0.4) |
Note:
*
P-value from testing the difference between men and women.
Abbreviation: CM, cutaneous melanoma.